Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2024
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin LymphomaChengcheng Yan, Melissa A Richard, Christopher J Gibson, et al.
JCI Insight|April 11, 2023
Cytokine storm-based mechanisms for extrapulmonary manifestations of SARS-CoV-2 infectionMaria Del Nogal Avila, Ranjan Das, Joubert Kharlyngdoh, et al.
Journal of the American Society of Nephrology : JASN|March 12, 2016
Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA NephropathyZhi Qiang Huang, Milan Raska, Tyler J Stewart, et al.
Cancers|July 2, 2021
Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell LinesLaura V Bownes, Adele P Williams, Raoud Marayati, et al.
Frontiers in Surgery|October 2, 2020
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade GliomasM R Chambers, R Timothy Bentley, David K Crossman, et al.
BMC Microbiology|January 14, 2016
Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficileRanjit Kumar, Craig L Maynard, Peter Eipers, et al.
Cancers|June 27, 2024
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D SignalingRadomir M Slominski, Tae-Kang Kim, Zorica Janjetovic, et al.
Cardio-Oncology (London, England)|May 17, 2025
Alternative mRNA splicing in anthracycline-induced cardiomyopathy - a COG-ALTE03N1 reportPurnima Singh, David K Crossman, Changde Cheng, et al.
Life Science Alliance|May 5, 2022
miR-486 is essential for muscle function and suppresses a dystrophic transcriptomeAdrienne Samani, Rylie M Hightower, Andrea L Reid, et al.
Journal of Ovarian Research|November 3, 2022
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancerRebecca M Borneman, Elaine Gavin, Alla Musiyenko, et al.
Pageof 16